A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Radiotracer for positron emission tomography against PKM2
Radiotracer for positron emission tomography against PKM2
Ukko eyes clinic with UKK-0018 for peanut allergy
Ukko eyes clinic with UKK-0018 for peanut allergy
Other news to note for Jan. 8, 2026
Other news to note for Jan. 8, 2026
Regulatory actions for Jan. 8, 2026
Regulatory actions for Jan. 8, 2026
Inflarx focuses on izicopan as biopharma spending cuts continue
Inflarx focuses on izicopan as biopharma spending cuts continue
Moonlake preps for sonelokimab BLA in HS; no new trials needed
Moonlake preps for sonelokimab BLA in HS; no new trials needed
FDA rejects Vanda’s Hetlioz for jet lag disorder
FDA rejects Vanda’s Hetlioz for jet lag disorder
Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B
Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B
Appeals court says no to cap on indirect costs in NIH grants
Appeals court says no to cap on indirect costs in NIH grants
Hetero Labs describes new tyrosine kinase inhibitors
Hetero Labs describes new tyrosine kinase inhibitors
New 3CLpro inhibitors disclosed in Nxera Pharma patent
New 3CLpro inhibitors disclosed in Nxera Pharma patent
Shanghai Huilun Pharmaceutical discovers new 5-HT2A receptor agonists
Shanghai Huilun Pharmaceutical discovers new 5-HT2A receptor agonists
Appointments and advancements for Jan. 7, 2026
Appointments and advancements for Jan. 7, 2026
Financings for Jan. 7, 2026
Financings for Jan. 7, 2026
In the clinic for Jan. 7, 2026
In the clinic for Jan. 7, 2026
Other news to note for Jan. 7, 2026
Other news to note for Jan. 7, 2026
Regulatory actions for Jan. 7, 2026
Regulatory actions for Jan. 7, 2026
AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil
AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page